Home4DN • FRA
add
Denali Therapeutics Inc
Previous close
€12.37
Day range
€12.54 - €12.54
Year range
€10.17 - €29.67
Market cap
2.06B USD
Avg Volume
12.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 130.44M | 12.54% |
Net income | -132.97M | -30.62% |
Net profit margin | — | — |
Earnings per share | -0.78 | -0.17% |
EBITDA | -143.26M | -10.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 817.93M | -12.70% |
Total assets | 1.27B | -19.59% |
Total liabilities | 148.66M | 18.34% |
Total equity | 1.12B | — |
Shares outstanding | 145.28M | — |
Price to book | 1.60 | — |
Return on assets | -27.51% | — |
Return on capital | -29.61% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -132.97M | -30.62% |
Cash from operations | -131.47M | -15.71% |
Cash from investing | 18.75M | 104.14% |
Cash from financing | -3.76M | -100.75% |
Net change in cash | -116.48M | -75.08% |
Free cash flow | -106.00M | -84.22% |
About
Founded
2013
Headquarters
Website
Employees
443
